BILLIE RAPOL: Open Payments
NPI 1518432897 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 26 payments from 16 companies in 2025. Trend: 2023 $325 · 2024 $518 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $105 |
| Amgen Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $32 |
| BETA BIONICS, INC. | 1 | $22 |
| ABIOMED | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
Products named: AIRSUPRA, QULIPTA, FARXIGA, EVENITY, MOUNJARO, iLet Bionic Pancreas, Dexcom G6 Transmitter, Kerendia.
Industry payments across NC — which companies pay providers there.
